Case Study of Atenolol

Atenolol, which is a cardioselective blocker of the beta-1 adrenergic receptors, is frequently used to treat hypertension, angina pectoris, and cardiac arrhythmias. The following is a case report of a 52-year-old man patient diagnosed with stage 2 hypertension (BP 168/102 mmHg) with a background history of exertional mild angina. Upon baseline assessment, the patient was started on Atenolol 50 mg daily. At 12-week follow-up, the patient demonstrated significant improvement in the control of blood pressure (mean BP lowered to 130/84 mmHg), reduction in the number of anginal attacks, and absence of serious side effects. Heart rate decreased from 88 bpm to 68 bpm with increased exercise tolerance. Slight fatigue was noticed in the initial period but subsided by the fourth week. The case highlights the ability of Atenolol to control both hypertension and accompanying angina, with an excellent safety profile in an outpatient environment. It is also underlines the need for individualized treatment, follow-up, and patient education on compliance and lifestyle change.